featured
Utility of ctDNA for Detecting Minimal Residual Disease Following Curative Surgery in Patients With Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis
Br. J. Cancer 2022 Nov 08;[EPub Ahead of Print], LG Faulkner, LM Howells, C Pepper, JA Shaw, AL ThomasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.